1. Home
  2. CVBF vs PBLS Comparison

CVBF vs PBLS Comparison

Compare CVBF & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVB Financial Corporation

CVBF

CVB Financial Corporation

N/A

Current Price

$21.96

Market Cap

4.0B

Sector

Finance

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$29.99

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVBF
PBLS
Founded
1974
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.6B
IPO Year
2009
2026

Fundamental Metrics

Financial Performance
Metric
CVBF
PBLS
Price
$21.96
$29.99
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$26.00
★ $41.75
AVG Volume (30 Days)
★ 1.1M
679.6K
Earning Date
10-21-2026
11-17-2026
Dividend Yield
★ 3.70%
N/A
EPS Growth
★ 5.56
N/A
EPS
★ 0.65
N/A
Revenue
N/A
N/A
Revenue This Year
$35.73
N/A
Revenue Next Year
$14.15
$222.58
P/E Ratio
$33.28
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.95
$25.56
52 Week High
$23.41
$42.49

Technical Indicators

Market Signals
Indicator
CVBF
PBLS
Relative Strength Index (RSI) 34.84 39.57
Support Level $19.89 $26.42
Resistance Level $21.48 $33.65
Average True Range (ATR) 0.38 3.16
MACD -0.10 -0.72
Stochastic Oscillator 0.62 20.05

Price Performance

Historical Comparison
CVBF
PBLS

About CVBF CVB Financial Corporation

CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit. It is a community bank with one reportable operating segment.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: